Systems and methods for third-party interoperability in secure network transactions using tokenized data
US-2024348616-A1 · Oct 17, 2024 · US
US8930208B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8930208-B2 |
| Application number | US-28361908-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 12, 2008 |
| Priority date | Apr 24, 2008 |
| Publication date | Jan 6, 2015 |
| Grant date | Jan 6, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent.
Opening claim text (preview).
What is claimed is: 1. A method comprising: accepting at least one indication of at least one bioactive agent used by an individual; selecting, using one or more computer processors, at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual; and presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent. 2. A system comprising: means for accepting at least one indication of at least one bioactive agent used by an individual; means for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual; and means for presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent. 3. A computer program product comprising: one or more non-transitory media including at least: one or more instructions for accepting at least one indication of at least one bioactive agent used by an individual; one or more instructions for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual; and one or more instructions for presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent. 4. A system comprising: a computing device; and one or more media including at least: one or more instructions for accepting at least one indication of at least one bioactive agent used by an individual; one or more instructions for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual; and one or more instructions for presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent. 5. A system comprising: circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual; circuitry configured for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual; and circuitry configured for presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent. 6. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one prescription medication used by an individual. 7. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one of the following types of bioactive agents used by an individual: an anti-depressant, an anxiolytic medication, a pain medication, a behavior modifying medication, a weight adjustment drug, an anti-Alzheimer's medication, or an anti-stroke medication. 8. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one bioactive agent abused by an individual. 9. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one of the following types of bioactive agents used by an individual: alcohol, psychoactive drug, tranquilizer, methamphetamine, tobacco, marijuana, or narcotic. 10. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one nutraceutical used by an individual. 11. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one of the following types of bioactive agents used by an individual: memory supplement, antioxidant, cancer preventative agent, weight adjustment agent, or mood-changing agent. 12. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one bioactive agent used by at least one of the following types of individuals: a computer game participant, a social networking tool user, a virtual world participant, an online student, an online medical information user, or an on-line shopper. 13. The system of claim 5 , wherein the circuitry configured for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual comprises: circuitry configured for selecting at least one virtual world experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual. 14. The system of claim 5 , wherein the circuitry configured for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual comprises: circuitry configured for selecting at least one of the following types of sensory experiences based at least partly on the at least one indication of the at least one bioactive agent used by the individual: virtual world, social networking, online game, single player game, or online educational experience. 15. The system of claim 5 , wherein the circuitry configured for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual comprises: circuitry configured for selecting at least one sensory experience based at least partly on at least one attribute of the individual and the at least one indication of the at least one bioactive agent used by the individual. 16. The system of claim 5 , wherein the circuitry configured for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual comprises: circuitry configured for selecting at least one visual stimulus based at least partly on the at least one indication of the at least one bioactive agent used by the individual. 17. The system of claim 5 , wherein the circuitry configured for pres
for remote operation · CPC title
relating to drugs or medications, e.g. for ensuring correct administration to patients · CPC title
Administration; Management · CPC title
Social work or social welfare, e.g. community support activities or counselling services · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.